CV Sciences, Inc.
CVSI · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6 | $5 | $4 | $13 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $1 | $0 | $2 | $1 |
| Enterprise Value | $6 | $5 | $5 | $12 |
| Revenue | $16 | $16 | $16 | $20 |
| % Growth | -1.9% | -1.2% | -19.2% | – |
| Gross Profit | $7 | $7 | $6 | $9 |
| % Margin | 45.6% | 44.3% | 34.2% | 43% |
| EBITDA | -$2 | $4 | -$6 | -$14 |
| % Margin | -11.8% | 24% | -34.9% | -69.8% |
| Net Income | -$2 | $3 | -$8 | -$16 |
| % Margin | -15.2% | 19.4% | -50.7% | -77.6% |
| EPS Diluted | -0.014 | 0.02 | -0.06 | -0.14 |
| % Growth | -167.7% | 133.8% | 57.5% | – |
| Operating Cash Flow | -$1 | $2 | -$2 | -$7 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$1 | $2 | -$2 | -$8 |